ICDcodes.org
FY2027

D61.82Myelophthisis

BillableCC

Is D61.82 billable?

Yes — D61.82 is billable for FY2027. D61.82 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D61.82 may be submitted for encounters from October 1, 2026 through September 30, 2027.

D61.82 at a glance

CodeD61.82
DescriptionMyelophthisis
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does D61.82 group to?

D61.82 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 820Lymphoma and Leukemia with Major O.R. Procedures with MCCsurgical
  • 821Lymphoma and Leukemia with Major O.R. Procedures with CCsurgical
  • 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCCsurgical

As a secondary diagnosis, D61.82 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

How is D61.82 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to D61.82. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Myelophthisis
  • Panmyelophthisis
  • Anemialeukoerythroblastic (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound)
  • Anemiamyelophthisic (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound)
  • Anemianormocyticmyelophthisic (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound)

Excludes1 — never code together

The conditions below can never be reported together with D61.82 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • idiopathic myelofibrosis (D47.1)
  • myelofibrosis NOS (D75.81)
  • myelofibrosis with myeloid metaplasia (D47.4)
  • primary myelofibrosis (D47.1)
  • secondary myelofibrosis (D75.81)

Code also

Two codes may be needed to describe the condition fully. Whether D61.82 is sequenced first depends on the reason for the encounter.

  • the underlying disorder, such as:
  • malignant neoplasm of breast (C50.-)
  • tuberculosis (A15.-)

Inclusion terms

Alternative wording in documentation that is classified to D61.82.

  • Leukoerythroblastic anemia
  • Myelophthisic anemia
  • Panmyelophthisis

Excludes2 — not included here — inherited from Chapter 3

The conditions below are not part of D61.82, but a patient may have both at the same time. When documentation supports it, D61.82 and the excluded code may both be reported.

  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Excludes2 — not included here — inherited from D61

The conditions below are not part of D61.82, but a patient may have both at the same time. When documentation supports it, D61.82 and the excluded code may both be reported.

How long has D61.82 existed?

D61.82 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

Which conditions are coded to D61.82?

What other codes are in the D61.8 family? (2)